2020
DOI: 10.1371/journal.pone.0230301
|View full text |Cite
|
Sign up to set email alerts
|

Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing

Abstract: The MGISEQ-2000 developed by MGI Tech Co. Ltd. (a subsidiary of the BGI Group) is a new competitor of such next-generation sequencing platforms as NovaSeq and HiSeq (Illumina). Its sequencing principle is based on the DNB and the cPAS technologies, which were also used in the previous version of the BGISEQ-500 device. However, the reagents for MGISEQ-2000 have been refined and the platform utilizes updated software. The cPAS method is an advanced technology based on the cPAL previously created by Complete Geno… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
43
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 63 publications
(49 citation statements)
references
References 20 publications
(35 reference statements)
0
43
0
Order By: Relevance
“…The overall sequencing quality was higher on the MGISEQ-2000 when compared to the BGISEQ-500, with more clean bases and clean reads produced. The sequencing technology implemented on each platform is the same -with the generation of a DNA Nanoball (DNB) and the cPAS method, where an oligonucleotide probe is added and attaches in combination to specific sites within the DNB [4,5]. Differences between the platforms may become clearer if longer read lengths are used (PE150) as read quality decreases over the entire read length.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The overall sequencing quality was higher on the MGISEQ-2000 when compared to the BGISEQ-500, with more clean bases and clean reads produced. The sequencing technology implemented on each platform is the same -with the generation of a DNA Nanoball (DNB) and the cPAS method, where an oligonucleotide probe is added and attaches in combination to specific sites within the DNB [4,5]. Differences between the platforms may become clearer if longer read lengths are used (PE150) as read quality decreases over the entire read length.…”
Section: Discussionmentioning
confidence: 99%
“…MGI Tech Co.Ltd (MGI), a subsidiary of BGI, released two new sequencing instruments, namely the MGISEQ-2000 and MGISEQ-200, in October 2017. These sequencers rely on MGI's proprietary DNBseq TM technology and the combinatorial Probe-Anchor Synthesis (cPAS) method, an improvement of the combinatorial Probe-Anchor Ligation (cPAL) sequencing technology, first patented by Complete Genomics [4,5]. As described by Korostin et al, the MGI-SEQ2000 is a complete alternative to the Illumina platform for similar tasks, including whole genome sequencing (WGS) [4].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It generates sequences in FASTQ format with quality scores based on a Phred-33 standard (equivalent to Illumina's NovaSeq system). Several studies have validated its sequencing quality by comparing its performance with that of Illumina generated sequence data from ancient DNA [24], whole-genome [25] and metagenome Fig. 1 Comparison of different strategies to access COI barcode using HTS platforms.…”
Section: Introductionmentioning
confidence: 99%
“…MGISEQ is compatible with a wide range of reagents for sequencing in SE50, SE100, SE400, PE100, PE150, and PE200 modes. MGISEQ-2000 provides the quality of sequencing comparable with that of the Illumina platform [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%